Categories: Latest

Eye-wear e-tailer Lenskart looks at 150% growth this fiscal

Kolkata, November 27, 2015: :Prescription eye-wear e-tailer Lenskart.com is looking to turn profitable, in 2017.

According to founder and CEO Peyush Bansal, the company is already “contribution margin positive” for fiscal 2016. This mean, at very early operational levels — which include direct channel expenses like cost of goods, payments and gateway charges — it is earning profits.

“By 2017, we should be EBITDA positive,” he told BusinessLine in an interview. The Faridabad-headquartered e-tailer is also looking at a 150 per cent increase in turnover to upwards of ₹200 crore by the end of this fiscal, against ₹80 crore last fiscal.

The domestic eye-wear market is estimated at ₹20,000 crore, with the organised segment accounting for around ₹2,000 crore. Lenskart is eyeing a 10 per cent market share in the organised segment.

According to Bansal, the e-tailer will invest ₹60 crore to expand capacities at its manufacturing facility at Okhla (Delhi), from the current 5,000 spectacles a day to 20,000.

The plant manufactures lenses. The company gets its frames contract manufactured from other parts of India, China, Korea and Italy. Compared to a regular optician who takes 20 minutes to make a pair of spectacles, Lenskart claims to make three units in 50 seconds, at 10 times more precision.

The company is also looking to ramp up its omni-channel presence, adding 250 brick-and-mortar stores every year. It has over 100 outlets at present operated on a franchisee model.

Customers can try out models in the outlets and place their orders online.

The off-line business is riding on the online one, with over 1,000 home appointments a day, said Bansal.

“We are really generating the trial and trust factor. In our view e-comm is beyond a desktop — it’s about building accessibility.”-BusinessLine

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Dr. Agarwals Eye Hospital Supports Nutritional Well-being of Children with Vehicle Donation to Akshaya Patra Foundation in Hubli

Hubli, May 20, 2024: In a significant move to support child nutrition through effective logistical contributions,…

18 hours ago

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

4 days ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

5 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

6 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

7 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420